Effect of escitalopram on CCK-4-induced panic disorders in CCK-4-sensitive volunteers.
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2012
At a glance
- Drugs Escitalopram (Primary)
- Indications Panic disorder
- Focus Pharmacogenomic; Therapeutic Use
- 03 Oct 2012 New trial record
- 29 Aug 2012 Results published in European Neuropsychopharmacology.